Unlock instant, AI-driven research and patent intelligence for your innovation.

CRISPR/Cas9 targeted knockout of the human TCab1 gene and its specific gRNA

A specific, genetic technology, applied in the field of molecular biology and biomedicine, can solve the problems of cancer cell death, cancer cell apoptosis, telomere formation and maintenance limitation, etc.

Active Publication Date: 2019-04-09
重庆威斯腾生物医药科技有限责任公司
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although the loss of TCAB1 expression does not affect the catalysis of the telomerase RNA component (TERC) by the active agent of telomerase reverse transcriptase (TERT), it can prevent the transport of the telomerase complex to the terminal end during the S phase of the cell. A synthesis site at the ends of telomeres, which ultimately leads to a restriction in the formation and maintenance of telomeres, resulting in shortened telomeres, which also means faster cancer cell death
Yuan Ping and others (Yuan Ping. Effect of RNAi silencing TCAB1 expression on the biological behavior of lung adenocarcinoma A549 cells [D]. Zhejiang University, 2014) using RNA interference technology can significantly inhibit the expression of TCAB1 mRNA and protein, and silencing TCAB1 expression can significantly inhibit the expression of TCAB1. Inhibit the combination of telomerase and telomere in lung adenocarcinoma cell A549 cells, and inhibit the proliferation of cancer cells, but the results of this study show that RNAi silencing can not cause apoptosis of cancer cells

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • CRISPR/Cas9 targeted knockout of the human TCab1 gene and its specific gRNA
  • CRISPR/Cas9 targeted knockout of the human TCab1 gene and its specific gRNA
  • CRISPR/Cas9 targeted knockout of the human TCab1 gene and its specific gRNA

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0017] Example 1 Synthesis of gRNA targeting human TCAB1 gene and construction of vector

[0018] 1. Selection and design of gRNA targeting human TCAB1 gene

[0019] The sequence of human TCAB1 gene was found in Genebank, and potential target sites were designed in the exon region of human TCAB1 gene. Through the online design tool (http: / / crispr.mit.edu / ) and the design principles of gRNA, the target site with high score on the human TCAB1 gene sequence is evaluated to design gRNA, and the target site sequence is SEQ ID NO.1-SEQ ID NO. ID NO.6, and design the corresponding oligonucleotide.

[0020] 2. Synthesis of gRNA oligonucleotide sequence targeting human TCAB1 gene and construction of eukaryotic expression vector

[0021] The pSpCas9(BB)-2A-GFP(PX458) plasmid (Addgene plasmid ID: 48138, hereinafter referred to as pSpCas9(BB)) was digested with BbSI, and after 1 hour in a water bath at 37°C, 1% agarose electrophoresis was used to recover the digestion. product (TAKARA ...

Embodiment 2

[0034] Example 2 Lipotransfection of HepG2 cells

[0035] Three days before transfection, revive human hepatoma cells (HepG2 cells, Shanghai Cell Bank, Chinese Academy of Sciences), put the cells into culture flasks with 10% FBS+DMEM, and store them at 37°C in 5% CO. 2 Cultured in an incubator, the day before transfection, subculture the recovered cells.

[0036]Aspirate the medium in the T75 flask for culturing HepG2 cells, add 2 ml of 0.25% trypsin taken out of the refrigerator at 4°C to evenly cover the bottom of the flask, place it in a 37°C incubator for 3-5 minutes, take it out, and shake to find that the cells are The bottom is detached, shake it all off, add 3ml of 10% DMEM preheated in a 37°C water bath, pipette with a 10ml pipette, pipette 6-8 times, without leaving dead corners, the bottle mouth is difficult to pipette and pipette The tube is aligned with the opening, and the medium is poured out with a small force to cover the cells close to the opening of the bot...

Embodiment 3

[0047] Example 3 PCR product cloning and sample sequencing detection

[0048] The PCR reaction was carried out according to the method of Example 2, and the PCR product was purified with the TAKARA kit and then connected to the PMD18-T carrier. The connection system was:

[0049]

[0050] Ligation for 2 hours at 16°C. Take the competent cell DH5α, put it on ice to thaw for 5min, add 10ul of the ligation product, blow evenly, and place it on ice for 20min. Heat shock at 42°C for 90s, quickly transfer to an ice bath and let stand for 3min, add 500ul of LB liquid medium, place in a shaker, 37°C 180rpm for 1h. Take 100ul of bacterial liquid and spread it evenly on LB solid medium (containing 1 / 1000AMP), and culture at 37°C overnight.

[0051] Pick 3 single colonies and put them into 3ml LB liquid medium (containing 3ul AMP) respectively, at 37°C and 200rpm for 12h. PCR identification was carried out with 1ul bacterial solution as a template, and all were positive. Bacteria ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of the molecular biology and the biomedicine, and particularly relates to application of a gRNA sequence based on a CRISPR / Cas9 system to cause tumor cell apoptosis. According to the design principle of CRISPR / Cas9, two target points are designed on a human genome, and corresponding oligos is synthesized and established on a px458 carrier. The CRISPR / Cas9 system guided by the gRNA is established in a human hepatoma cell line (HepG2) according to the design of the two target points, a human TCAB1 gene can be effectively knocked out, the system is easy to operate, and the knockout efficiency of the human TCAB1 gene is high. The CRISPR / Cas9 system guided by the gRNA can be expected to be applied in novel tumor treating medicine.

Description

technical field [0001] The invention belongs to the technical field of molecular biology and biomedicine, in particular to the application of a CRISPR / Cas9 system-based gRNA sequence in promoting tumor cell apoptosis. Background technique [0002] The CRISPR / Cas system is developed from the adaptive immune system of bacteria and archaea against foreign viruses or plasmids, including three different types, of which the Type II CRISPR / Cas system has only one DNA endonuclease Cas9. The structure is the simplest, so it is the most widely used. In addition to the Cas9 protein, the system includes two short CRISPR RNAs (crRNAs) and trans-activating crRNAs (tracrRNA). The mature crRNA-tracrRNA complex can guide the Cas9 protein to the target sequence through complementary base pairing, and specifically cleave the DNA double strand near the PAM (protospacer adjacent motif) to form DSB (double strand break). DSB can be repaired in two ways, one is the non-homologous end joining (NH...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N15/113A61P35/00
CPCC12N9/1276C12N15/1137C12N2310/10C12Y207/07049
Inventor 周勇申友锋
Owner 重庆威斯腾生物医药科技有限责任公司